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Abstract Vitamin D3, cholecalciferol, induces cell<ell communication via gap junctions in murine fibroblasts (C3H/lOT 112 cells) at concentrations 
between 0.01 and 1 .O PM, as assayed by the dye transfer method using Lucifer yellow CH. The extent of induction is similar to that obtained with the 
positive controls, canthaxanthin or retinoic acid, applied at 10 and 1 ,uM, respectively. Vitamin D2 also induces cell~ll communication. At elevated 
concentrations of vitamin D3 (5 PM) there is a suppression of gap junctional communication, reversible upon exposure to all-tram retinoic acid 
(1 PM) after removal of vitamin D3 from the medium. Conversely, communication between cells prestimulated with retinoic acid (1 PM) rapidly 
decreases when the retinoid is replaced by vitamin D3 (5 ,uM). The data demonstrate a role for vitamin D in the regulation of intercellular 
communication. This novel property of vitamin D may contribute to the antiproliferative ffects of vitamin D exhibited in some types of cancer. 
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1. Introduction 
Vitamin D contributes to the regulation of gene expression 
through the metabolite, 1,25-(OH), vitamin D3, a ligand of the 
vitamin D nuclear receptor (VDR). The vitamin D-responsive 
systems include genes governing oncogene and lymphokine ex- 
pression and replication-linked genes critical for cell prolifera- 
tion [l]. Growth regulatory functions in cells are also attributed 
to gap junctional communication which can be induced by 
retinoids [2-51 and carotenoids [6]. 
Recently, a signalling pathway has been described which is 
responsive to heterodimers of VDR and the retinoic X receptor 
a (RXRa). The DNA responsive lement is synergistically acti- 
vated by VDR and RXR, and the presence of both ligands, 
1,2.5-(OH), D, and 9-cis retinoic acid, is necessary for activation 
[71. 
In the present study, we investigated the influence of vitamin 
D3 on cell<ell communication and its interplay with all-trans 
retinoic acid. 
2. Materials and methods 
2.1. Chemicals 
Lucifer yellow CH and all-trans retinoic acid were purchased from 
Sigma (Deisenhofen, Germany), vitamins D3 and D2 from Fluka (Neu- 
Urn, Germany). Canthaxanthin was a kind gift from Dr. J. Bausch, 
Hoffmann-La Roche (Base], Switzerland). The cell proliferation kit I 
(MTT) was from Boehringer (Mannheim, Germany). All other chemi- 
cals were obtained from Merck (Darmstadt, Germany). 
2.2. Cells and culture conditions 
The murine embryo fibroblast C3HIlOT l/2 clone 8 cell line (ATCC, 
No. CCL 226) was cultured with fibroblast growth medium FGM from 
PromoCell (Heidelberg, Germany) supplemented with 10% fetal calf 
serum from Life Technologies (Eggenstein, Germany) in 35 x 10 mm 
dishes from Nunc (Wiesbaden, Germany). When confluence was 
reached, the fetal calf serum content was decreased to 31, and the cells 
were then treated with the indicated concentrations of vitamins D3 or 
D2, dissolved in acetone. Canthaxanthin (10 PM) dissolved in tetrahy- 
drofuran was used as a positive control [6]. The medium containing the 
*Corresponding author. Fax: (49) (211) 311 3029. 
respective compounds added for the experiment was exchanged every 
3 days. Cells were washed twice with PBS before new medium was 
added. The final concentration of acetone or tetrahydrofuran in the 
culture medium was 0.5%. Cell viability was checked determining the 
activity of mitochondrial dehydrogenases (cell proliferation kit I) fol- 
lowing the protocol provided by the supplier. 
2.3. Gap junctional communication assay 
On days 1,3,5,8,10 and 12 of the incubation, junctional communi- 
cation was assayed by microinjection of the fluorescent dye Lucifer 
yellow CH (10% in 0.33 M LiCl, w/v) into cells of confluent cultures 
by means of a microinjector and micromanipulator (Eppendorf, Ham- 
burg, Germany). The number of fluorescent neighbors of the injected 
cells was scored 5 min after injection and serves as an index of junc- 
tional communication [8]. The data plotted in the figures are mean 
values (+ S.E.M.) of 10 individual injections of cells. Each experiment 
was repeated in triplicate with essentially the same results. 
3. Results 
Upon incubation of the cells with vitamin D3 the intercellular 
communication of C3H/lOT 112 cells increased markedly above 
the solvent control (Fig. 1). Similar effects were obtained with 
vitamin D2 (data not shown). With concentrations of 0.01 and 
0.1 PM the increase in the number of communicating cells was 
similar to that obtained with the positive control, canthaxan- 
thin (10pM). Gap junctional communication rose continuously 
up to day 12 of treatment. 
Cell&z11 communication decreased with higher concentra- 
tions of vitamin D3. At day 12, significantly less communica- 
tion was observed in cultures treated with 1 ,uM vitamin D3 as 
compared to incubations containing lower (0.01 and 0.1 PM) 
concentrations. Moreover, almost complete loss of intercellular 
communication was achieved with 5 PM vitamin D3, reflected 
by a level significantly below the solvent control, already even 
on day 1 (Fig. 1). 
No overt morphological changes or toxic effects, as checked 
by mitochondrial dehydrogenase activity, were detected as a 
result of vitamin D treatment at the concentrations employed. 
After continuous inhibition (9 days) by exposure to vitamin 
D3 at 5 PM concentration, the intercellular communication of 
10T 112 cells was restimulated when vitamin D3 in the medium 
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Fig. 1. Increase of gap junctional communication in murine C3H110 T 
112 fibroblasts upon treatment with different concentrations of vitamin 
D3. Vitamin D3 was added at the concentrations of 0.01 PM (v), 0.1 
PM (v), 1 .O ,uM (o), and 5.0 PM (0). Solvent control was 0.5% acetone 
(0). The positive control was 1OflM canthaxanthin i  0.5% tetrahydro- 
furan (e). Solvent control for tetrahydrofuran is not shown, it was 
similar to 0.5% acetone. 
was exchanged for 1 ,uM retinoic acid (Fig. 2, dotted arrow). 
Within 24 h a cell-cell communication in the range of the 
controls was observed, further increasing between days 10 and 
14, the slope being comparable to that observed for 1 ,BM 
retinoic acid alone (top curve in Fig. 2). When the vitamin 
D3-containing medium was exchanged for solvent control on 
day 9, a slight increase in communication occurred as well, 
amounting to about 10 communicating cells on day 14 (not 
shown in Fig. 2). 
Conversely, cell-cell communication in cells prestimulated 
with 1 ,uM retinoic acid (top curve in Fig. 2) was inhibited by 
exchanging retinoic acid in the medium for 5 PM of vitamin D3 
on day 9 (Fig. 2, solid arrow). Solvent controls decreased 
slightly towards about 75 communicating cells on day 14 (not 
shown). 
4. Discussion 
Cell culture assays for chemicals with tumor-promoting or 
tumor-inhibiting activity based on the modulation of intercellu- 
lar communication have been widely used [9]. The present 
work, to our knowledge, is the first report describing the influ- 
ence of vitamin D on gap junctional communication, a process 
relevant in the regulation of cell growth and differentiation. The 
data suggest hat calciferols and retinoids interplay in the regu- 
latory process of gap junctional activity. It has been suggested 
that retinoic acid nuclear receptors are involved in the activa- 
tion of the expression of connexins, a family of proteins form- 
ing the transmembrane channels [lo]. The mechanism of action 
of the calciferols is yet unknown. As mentioned above, recently 
a signalling pathway has been described utilizing heterodimers 
between vitamin D receptors and retinoic acid receptors in the 
presence of their natural ligands [7]. Thus, it appears that vita- 
min D plays a role in the regulation of gap junctional commu- 
nication through regulation of gene expression. 
Furthermore, it should be noted that cellular calcium con- 
centrations influence gap junctional permeability. With ele- 
vated concentrations of cytosolic calcium, less communication 
is observed [111. The rapid suppression of cell&cell communica- 
tion upon addition of high (5 FM) vitamin D3 concentrations 
(Fig. 1, day 1; Fig. 2, day 10 after removal of retinoic acid on 
day 9) could be due to increased calcium levels. This implies two 
different vitamin D-dependent regulatory mechanisms of inter- 
cellular communication, one being activatory, by regulation of 
connexin gene expression as described for retinoids. The other 
mechanism is inhibitory, observed at high vitamin D concentra- 
tions, possibly operating through changes in cellular calcium 
levels. 
A variety of physiological functions have been attributed to 
vitamin D, predominantly related to calcium homeostasis, in- 
cluding intestinal calcium uptake, bone remodeling or mineral 
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Fig. 2. Interplay of vitamin D3 and all-tram retinoic acid in modulating 
gap junctional communication. Cells were treated with 5 ,uM vitamin 
D3 (o), and on day 9 the medium was exchanged for 1 PM all-tram 
retinoic acid (v), indicated by dotted arrow. Conversely, cells were 
treated with 1 PM all-tram retinoic acid ( l ), and on day 9 the medium 
was exchanged for 5 ,uM vitamin D3 (v), indicated by solid arrow. 
Solvent controls are indicated as (0). 
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conservation in the kidney [12,13]. Vitamin D, its metabolites 
and several synthetic analogs have been shown to promote 
differentiation and inhibit the proliferation of several cancer 
cell lines in vitro, e.g. the human myeloid leukemia cell line 
HL-60 [ 141, breast cancer [ 151, colon cancer [ 161, and prostatic 
cancer cell lines [17,18]. In tumor-bearing animals, vitamin D 
derivatives uppressed tumor growth, inhibited metastasis, and 
prolonged survival times [19,20]. It appears feasible that some 
of these effects are mediated through modulation of intercellu- 
lar communication. 
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